Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 269Active not recruiting 138Completed 111Not yet recruiting 56Terminated 47Withdrawn 8Enrolling by invitation 4Suspended 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 51Breast Neoplasms 42Colorectal Neoplasms 26Prostatic Neoplasms 22Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Stomach Neoplasms 14Carcinoma, Hepatocellular 14Hematologic Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Colonic Neoplasms 9Uterine Cervical Neoplasms 8Urinary Bladder Neoplasms 8Lymphoma, Follicular 8Ovarian Neoplasms 7Melanoma 7Liver Neoplasms 7Leukemia, Myeloid, Acute 7Head and Neck Neoplasms 7Disease 7Anxiety Disorders 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myasthenia Gravis 6Barrett Esophagus 6Sarcoma 5Rectal Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Leukemia, Lymphocytic, Chronic, B-Cell 5

Interventions

Tramadol 1Pregabalin 1Naproxen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Squamous Cell Carcinoma of Head and Neck × 1 year × Clear all
NCT07606638 2026-05-26

Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients

Mayo Hospital Lahore

Phase NA Enrolling by invitation
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT06885424 2026-05-20

DESCENT-1

A2 Biotherapeutics Inc.

Enrolling by invitation
400 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07550972 2026-04-24

Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.

Zhejiang Provincial People's Hospital

Phase 2 Enrolling by invitation
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07532928 2026-04-16

A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data

Nanfang Hospital, Southern Medical University

Enrolling by invitation
571 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡